Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oric Pharmaceuticals Inc.

5.09
-0.0100-0.20%
Pre-market: 5.290.2027+3.98%08:00 EDT
Volume:416.39K
Turnover:2.15M
Market Cap:361.53M
PE:-2.78
High:5.42
Open:5.09
Low:5.05
Close:5.10
Loading ...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
04 Jan

We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth

Simply Wall St.
·
12 Dec 2024

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
26 Nov 2024

Oric Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Stifel Nicolaus Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC)

TIPRANKS
·
13 Nov 2024

ORIC Pharmaceuticals GAAP EPS of -$0.49 in-line

seekingalpha
·
13 Nov 2024

ORIC Pharmaceuticals Q3 EPS $(0.49) Misses $(0.47) Estimate

Benzinga
·
13 Nov 2024

Oric Pharmaceuticals reports Q3 EPS (49c), consensus (48c)

TIPRANKS
·
13 Nov 2024

Promising Advancements in Cancer Treatment: Buy Rating for ORIC Pharmaceuticals

TIPRANKS
·
13 Nov 2024

BRIEF-ORIC Pharmaceuticals Q3 Net Income USD -34.566 Million

Reuters
·
13 Nov 2024

Oric Pharmaceuticals Inc: Cash and Investments of $282.4 Mln Expected to Fund Operating Plan Into Late 2026

THOMSON REUTERS
·
13 Nov 2024

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

GlobeNewswire
·
13 Nov 2024

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
05 Nov 2024

Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Nov 2024

Positive Outlook on ORIC-114: Promising Preclinical Results and Selective Efficacy Bolster Buy Rating

TIPRANKS
·
04 Nov 2024

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 Nov 2024

Oric Pharmaceuticals Initiated at Overweight by Wells Fargo

Dow Jones
·
01 Nov 2024

JonesTrading Initiates ORIC Pharmaceuticals at Buy With $17 Price Target

MT Newswires Live
·
31 Oct 2024